Related Experiment Video
Updated: Aug 12, 2026
09:36
Changes in Mammary Gland Morphology and Breast Cancer Risk in Rats
Published on: October 16, 2010
Breast cancer in pregnancy
1Department of Obstetrics and Gynecology, Brown University School of Medicine, Providence, RI 02905.
Clinical Obstetrics and Gynecology
|December 1, 1994
Summary
Pregnancy-associated breast cancer prognosis is not inherently poor; survival rates are similar to non-pregnancy breast cancer when diagnosed at the same stage. Early detection and appropriate treatment are key for better outcomes.
Area of Science:
- Oncology
- Maternal-Fetal Medicine
- Public Health
Background:
- The historical perception of poor prognosis for breast cancer during pregnancy is challenged.
- Late-stage presentation is a primary contributor to historically observed adverse outcomes.
Purpose of the Study:
- To re-evaluate the prognosis of pregnancy-associated breast cancer (PABC).
- To emphasize the importance of considering breast cancer in prenatal diagnostics.
- To provide guidance on management strategies for PABC.
Main Methods:
- Comparative analysis of survival rates between PABC and non-PABC cohorts.
- Review of diagnostic considerations and treatment modalities for PABC.
- Evaluation of the impact of pregnancy termination on survival.
Main Results:
- When matched for stage at presentation and lymph node status, 5- and 10-year survival rates for PABC are identical to non-PABC.
- Early breast examinations during prenatal visits are recommended.
- Modified radical mastectomy is advised for operable disease in the first and second trimesters; chemotherapy may be considered in the second and third trimesters.
Conclusions:
- Pregnancy itself does not confer a worse prognosis for breast cancer.
- Timely diagnosis and stage-appropriate treatment are critical for optimizing survival in PABC.
- Termination of pregnancy does not improve survival outcomes for breast cancer patients.
More Related Videos
08:34Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
13:43Intraductal Delivery and X-ray Visualization of Ethanol-Based Ablative Solution for Prevention and Local Treatment of Breast Cancer in Mouse Models
Published on: April 1, 2022
Related Concept Videos
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:24Disorders of the Female Reproductive System
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
01:19Mitral Valve Prolapse III: Nursing Management
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...